About Hexon Laboratories Private Limited
Data last updated:
Hexon Laboratories Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24119MH2007PTC377645. Its GSTIN is 27AABCH8835Q1ZU (Maharashtra).
The company has an authorised share capital of ₹1.84 Cr and a paid-up capital of ₹80 Lakh. It is led by directors Savita Chandrashekhar Kotkar and Chandrashekhar Yashwant Kotkar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. B 19/22 Near Taj Hotel, Nashik (M. Corp), Maharashtra, India – 422010.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.96 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹17.91 Lakh (net margin 4.5%) and EBITDA of ₹62.67 Lakh (EBITDA margin 15.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹3.4 Cr and satisfied charges of ₹43.25 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hexonlab.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. B 19/22 Near Taj Hotel, Nashik (M. Corp), Maharashtra, India – 422010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Hexon Laboratories Private Limited
The main business activity of Hexon Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Hexon Laboratories Private Limited FY 2024 filings available
Hexon Laboratories Private Limited reported revenue of ₹3.96 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Hexon Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 26% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Hexon Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹62.67 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17.91 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Hexon Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hexon Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Hexon Laboratories Private Limited
Hexon Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KD Chem Pharma Private Limited | ₹3.98 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Ahmedabad, Gujarat, India |
| Delta Bioscience Private Limited | ₹3.97 Cr (FY 2025) | •••• | •••• | -50.0% | •••• | Chandigarh, India |
| Qualitron Bio Medica Private Limited | ₹3.97 Cr (FY 2024) | •••• | •••• | 2804.0% | •••• | Thane, Maharashtra, India |
| Genkomax Sciences Private Limited | ₹3.96 Cr (FY 2022) | •••• | •••• | 30.0% | •••• | Patna, Bihar, India |
| Velsparkx Labs Private Limited | ₹3.96 Cr (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Hexon Laboratories Private Limited this company | ₹3.96 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Nashik, Maharashtra, India |
| Pharmaids Pharmaceuticals Limited Listed | ₹3.95 Cr (FY 2022) | •••• | •••• | -54.0% | •••• | Bangalore, Karnataka, India |
| Zeyyer Pharmaceuticals Private Limited | ₹3.95 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Govindapuram, Kerala, India |
| Zymonutrients Private Limited | ₹3.95 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Hebbal, Mysore, Karnataka, India |
| Pharmagenica Healthcare Private Limited | ₹3.95 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Bangalore, Karnataka, India |
| Ib Indian Biologicals Private Limited | ₹3.94 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Hexon Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Hexon Laboratories Private Limited
Hexon Laboratories Private Limited is audited by RAJARAM & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJARAM & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Hexon Laboratories Private Limited
Hexon Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Savita Chandrashekhar Kotkar | Director | 12 Jun 2007 | 19 Years 3 Months | Current |
| Chandrashekhar Yashwant Kotkar | Director | 12 Jun 2007 | 19 Years 3 Months | Current |
Ownership and Shareholding of Hexon Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hexon Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2025 | Sidbi | ₹50 Lakh | Open |
| 11 May 2023 | Sidbi | ₹2.4 Cr | Open |
| 25 Feb 2015 | State Bank of India | ₹50 Lakh | Open |
| 28 Jan 2015 | Hdfc Bank Limited | ₹8.5 Lakh | Satisfied |
| 28 Jan 2015 | Hdfc Bank Limited | ₹8.5 Lakh | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Hexon Laboratories Private Limited
Employment history and EPFO contributions of people linked to Hexon Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Hexon Laboratories Private Limited
Hexon Laboratories has one previous CIN (Corporate Identification Number): U24119PN2007PTC130304. The current CIN is U24119MH2007PTC377645, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24119MH2007PTC377645 | Current |
| U24119PN2007PTC130304 | Previous |
Recent Activity on Hexon Laboratories Private Limited
Hexon Laboratories Private Limited has 2 board changes on record since 2007: 2 appointments. The latest: Chandrashekhar Yashwant Kotkar was appointed as Director on 12 Jun 2007.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Hexon Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hexon Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hexon Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hexon Laboratories Private Limited
Hexon Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCH8835Q1ZU | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hexon Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hexon Laboratories Private Limited
Hexon Laboratories is an active private limited company based in Nashik, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 2007 (19+ years old) and is registered under CIN U24119MH2007PTC377645.
Hexon Laboratories reported revenue of ₹3.96 Cr for FY 2025 (up 26% YoY).
Hexon Laboratories has 2 current directors:
- Savita Chandrashekhar Kotkar - Director
- Chandrashekhar Yashwant Kotkar - Director
Hexon Laboratories reported a net profit of ₹17.91 Lakh (net margin 4.5%) and EBITDA of ₹62.67 Lakh (EBITDA margin 15.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Hexon Laboratories is -2% over three years and 19% over five years. In the latest year (FY 2025) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Hexon Laboratories is 27AABCH8835Q1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Hexon Laboratories is U24119MH2007PTC377645. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hexon Laboratories was incorporated on 12 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Hexon Laboratories by revenue are KD Chem Pharma Private Limited, Delta Bioscience Private Limited, Qualitron Bio Medica Private Limited, Genkomax Sciences Private Limited, Velsparkx Labs Private Limited and 5 more, all in the Pharma industry (Formulations).
Chandrashekhar Yashwant Kotkar was appointed as Director on 12 Jun 2007. Savita Chandrashekhar Kotkar was appointed as Director on 12 Jun 2007.
Hexon Laboratories can be reached through the website hexonlab.com. Its registered office is in Nashik, Maharashtra, India.